111 Capital’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-4,916
Closed -$738K – 654
2026
Q2
$738K Buy
+4,916
New +$535K 0.13% 165
2025
Q1
– Sell
-8,303
Closed -$254K – 512
2024
Q4
$254K Buy
+8,303
New +$234K 0.05% 324

Other funds holding GH

111 Capital's GH Position: Q3 2026 in Review

111 Capital sold out of Guardant Health (GH) in Q3 2026, closing a stake of 4,916 shares — an estimated $738K sold.

111 Capital first reported a position in GH in Q4 2024 and held it in 2 quarters. The position peaked at $738K in Q2 2026. 225 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • 111 Capital reported no remaining Guardant Health position as of Q3 2026 after selling out during the quarter.
  • 111 Capital sold 4,916 Guardant Health shares in Q3 2026, an estimated $738K.
  • 111 Capital first reported a position in Guardant Health in Q4 2024 and held it in 2 quarters.
  • 111 Capital's Guardant Health position peaked at $738K in Q2 2026.
  • 225 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on 111 Capital's 13F filing for Q3 2026, filed 3 Nov 2026.